ATOM vs EXAS · rev $135.0K vs rev $2.76B
Atomera Inc (ATOM) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ATOM currently screens at market cap $341.1M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ATOM and EXAS stock pages for the full models.
Not investment advice.